Skip to main content

Table 1 Characteristics of patients with tuberculosis according to the treatment outcome at the Jamot Hospital in 2009

From: HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study

Characteristics

Categories

Total

Outcomes of tuberculosis treatment

Cured/Completed*

Failure

Deaths

Defaulted

Transferred

P-value

N(%)

 

1647

1121 (68.1)

6 (0.4)

86 (5.2)

331 (20.1)

103 (6.3)

 

Age, years, n(%)

        
 

≤33

854 (51.9)

609 (71.3)

2 (0.2)

24 (2.8)

172 (20.1)

47 (5.5)

<0.001

 

>33

793 (48.1)

512 (64.6)

4 (0.5)

62 (7.8)

159 (20.1)

56 (7.1)

 
 

Mean (SD)

35.5 (13.2)

35.3 (12.9)

37.3 (13.7)

43.9 (14)

35.7 (13.3)

37.1 (13.9)

<0.001

Men, n (%)

 

938 (57)

635 (67.7)

4 (0.4)

50 (5.3)

194 (20.7)

55 (5.9)

0.467

Urban residence, n (%)

 

1390/1622 (85.7)

968 (69.6)

5 (0.4)

72 (5.2)

278 (20)

67 (4.8)

<0.001

Clinical forms, n (%)

        
 

PTB+

1216 (73.8)

845 (69.5)

6 (0.5)

56 (4.6)

239 (19.7)

70 (5.7)

<0.001

 

PTB-

155 (9.4)

86 (55.5)

0 (0)

16 (10.3)

42 (27.1)

11 (7.1)

 
 

EPTB

276 (16.8)

190 (68.8)

0 (0)

14 (5.1)

50 (3.7)

22 (8.0)

 

Type of patient, n (%)

        
 

New cases

1505 (91.4)

1026 (68.2)

5 (0.3)

81(5.4)

295 (19.6)

98 (6.5)

0.27

 

Relapse

119 (7.2)

81(68.1)

1 (0.8)

5 (4.2)

28 (23.5)

4 (3.4)

 
 

Failure

3 (0.2)

2 (66.7)

0 (0)

0 (0)

0 (0)

1 (33.3)

 
 

Defaulters

20 (1.2)

12 (60)

0 (0)

0 (0)

8 (40)

0 (0)

 

HIV serology, n (%)

        
 

Not done

228 (13.8)

113 (49.6)

2 (0.9)

20 (8.8)

69 (30.3)

24 (10.5)

<0.001

 

Negative

922/1419 (65)

685 (74.3)

4 (0.4)

17 (1.8)

166 (18)

50 (5.4)

<0.001

 

Positive

497/1419 (35)

323 (65.0)

0 (0)

49 (9.8)

96 (19.3)

29 (5.8)

 
  1. SD, standard deviation; EPTB, extra-pulmonary tuberculosis ; PTB+, smear positive pulmonary tuberculosis ; PTB-, smear negative pulmonary tuberculosis; cured + completed = therapeutic success.